Currently, there are 433.63M common shares owned by the public and among those 354.90M shares have been available to trade.
The company’s stock has a 5-day price change of 16.56% and -25.28% over the past three months. XP shares are trading 12.24% year to date (YTD), with the 12-month market performance down to -47.56% lower. It has a 12-month low price of $10.82 and touched a high of $26.51 over the same period. XP has an average intraday trading volume of 6.78 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 11.95%, 0.65%, and -23.52% respectively.
Institutional ownership of XP Inc (NASDAQ: XP) shares accounts for 58.91% of the company’s 433.63M shares outstanding.
It has a market capitalization of $7.18B and a beta (3y monthly) value of 1.60. The stock’s trailing 12-month PE ratio is 8.66, while the earnings-per-share (ttm) stands at $1.53. The company has a PEG of 0.83 and the debt-to-equity ratio at 3.57. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.57% over the week and 3.63% over the month.
Earnings per share for the fiscal year are expected to increase by 8.34%, and 10.76% over the next financial year. EPS should shrink at an annualized rate of 10.39% over the next five years, compared to 44.60% over the past 5-year period.
Looking at the support for the XP, a number of firms have released research notes about the stock. UBS stated their Buy rating for the stock in a research note on January 24, 2025, with the firm’s price target at $19-$16. BofA Securities coverage for the XP Inc (XP) stock in a research note released on December 10, 2024 offered a Neutral rating with a price target of $16. UBS was of a view on July 11, 2024 that the stock is Neutral, while Goldman gave the stock Neutral rating on April 30, 2024, issuing a price target of $30- $23. Morgan Stanley on their part issued Equal-Weight rating on April 23, 2024.
